8-K Announcements
6Material company update
Apr 21, 2026·SEC
Material company update
Apr 17, 2026·SEC
Material company update
Feb 17, 2026·SEC
Danaher Corporation(DHR)Earnings, Financials & Key Ratios
DHR•NYSE
35.2× P/E·Price updated Jun 19, 2026
SectorHealthcareIndustryDiagnostics & ResearchSub-IndustryLife Science Instruments and Sequencing Tools
AboutDanaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.Show more
- Revenue$24.57B+2.9%
- EBITDA$7.58B+0.6%
- Net Income$3.61B-7.3%
- EPS (Diluted)5.04-4.7%
- Gross Margin60.93%+2.4%
- EBITDA Margin30.87%-2.2%
- Operating Margin20.91%-3.7%
- Net Margin14.71%-9.9%
- ROE7.08%-6.4%
DHR Key Insights
Danaher Corporation (DHR) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 7/9
- ✓FCF machine: 21.4% free cash flow margin
- ✓High quality earnings: Operating CF exceeds net income
- ✓Share count reduced 3.6% through buybacks
- ✓Healthy 5Y average net margin of 20.0%
✗Weaknesses
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when DHR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
DHR Price & Volume
Danaher Corporation (DHR) stock price & volume — 10-year historical chart
Loading chart...
DHR Growth Metrics
Danaher Corporation (DHR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years5.46%
5 Years1.97%
3 Years-2.67%
TTM4.02%
Profit CAGR
10 Years3.36%
5 Years-0.18%
3 Years-20.56%
TTM-2.02%
EPS CAGR
10 Years0.62%
5 Years0.61%
3 Years-19.44%
TTM0.39%
Return on Capital
10 Years7.82%
5 Years8.43%
3 Years6.99%
Last Year6.97%
DHR Recent Earnings
Danaher Corporation (DHR) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
Apr 21, 2026Metric
Actual
Est
EPS
$2.06+6.2%
$1.94
Rev
$6.0B-0.5%
$6.0B
Q1 2026
Jan 28, 2026Metric
Actual
Est
EPS
$2.23+3.2%
$2.16
Rev
$6.8B+0.4%
$6.8B
Q4 2025
Oct 21, 2025Metric
Actual
Est
EPS
$1.89+9.9%
$1.72
Rev
$6.1B+0.9%
$6.0B
Q3 2025
Jul 22, 2025Metric
Actual
Est
EPS
$1.80+9.8%
$1.64
Rev
$5.9B+1.7%
$5.8B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 21, 2026 | $2.06vs $1.94+6.2% | $6.0Bvs $6.0B-0.5% |
| Q1 2026 | Jan 28, 2026 | $2.23vs $2.16+3.2% | $6.8Bvs $6.8B+0.4% |
| Q4 2025 | Oct 21, 2025 | $1.89vs $1.72+9.9% | $6.1Bvs $6.0B+0.9% |
| Q3 2025 | Jul 22, 2025 | $1.80vs $1.64+9.8% | $5.9Bvs $5.8B+1.7% |
Based on last 12 quarters of dataView full earnings history →
DHR Peer Comparison
Danaher Corporation (DHR) competitors in Life Science Instruments and Sequencing Tools — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 TMO | 172.66B | 464.61 | 26.19 | 3.91% | 15.18% | 13.23% | 0.76 | |
 A | 35.89B | 127.06 | 27.80 | 6.73% | 19.55% | 20.84% | 0.50 | |
 WAT | 23.17B | 355.44 | 33.03 | 6.99% | 11.91% | 8.04% | 0.55 | |
 BIO | 7.63B | 282.44 | 10.13 | 0.65% | 6.52% | 2.4% | 0.21 | |
 BRKR | 8.71B | 57.23 | -381.53 | 2.08% | -0.34% | -0.5% | 0.81 | |
 MTD | 23.13B | 1144.84 | 27.15 | 3.98% | 21.4% | |||
 IDXX | 44.64B | 562.09 | 42.97 | 10.42% | 24.63% | 70.87% | 0.67 | |
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 11.01% | 0.52 |
Compare DHR vs Peers
Danaher Corporation (DHR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
DHR Income Statement
Danaher Corporation (DHR) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 18.33B | 17.05B | 17.91B | 22.28B | 29.45B | 26.64B | 23.89B | 23.88B | 24.57B | 24.78B |
Revenue Growth % | 8.57% | -6.99% | 5.06% | 24.41% | 32.17% | -9.54% | -10.33% | -0.06% | 2.9% | 4.02% |
Cost of Goods Sold | 8.1B | 7.54B | 7.93B | 9.81B | 11.5B | 10.46B | 9.86B | 9.67B | 9.6B | 9.74B |
COGS % of Revenue | 44.19% | 44.25% | 44.26% | 44.02% | 39.05% | 39.24% | 41.26% | 40.5% | 39.07% | - |
Gross Profit | 10.23B▲ 0% | 9.51B▼ 7.1% | 9.98B▲ 5.0% | 12.47B▲ 25.0% | 17.95B▲ 43.9% | 16.19B▼ 9.8% | 14.03B▼ 13.3% | 14.21B▲ 1.2% | 14.97B▲ 5.4% | 15.04B▲ 0% |
Gross Margin % | 55.81% | 55.75% | 55.74% | 55.98% | 60.95% | 60.76% | 58.74% | 59.5% | 60.93% | 60.68% |
Gross Profit Growth % | 9.03% | -7.09% | 5.03% | 24.95% | 43.9% | -9.83% | -13.31% | 1.23% | 5.38% | - |
Operating Expenses | 7.08B | 6.44B | 6.62B | 8.16B | 9.9B | 8.65B | 8.76B | 9.02B | 9.83B | 9.84B |
OpEx % of Revenue | 38.63% | 37.75% | 36.97% | 36.63% | 33.62% | 32.47% | 36.65% | 37.79% | 40.02% | - |
Selling, General & Admin | 5.95B | 5.38B | 5.5B | 6.82B | 8.16B | 7.12B | 7.25B | 7.44B | 8.23B | 8.24B |
SG&A % of Revenue | 32.47% | 31.53% | 30.68% | 30.58% | 27.71% | 26.74% | 30.36% | 31.15% | 33.52% | - |
Research & Development | 1.13B | 1.06B | 1.13B | 1.35B | 1.74B | 1.53B | 1.5B | 1.58B | 1.6B | 1.61B |
R&D % of Revenue | 6.16% | 6.21% | 6.29% | 6.05% | 5.91% | 5.74% | 6.29% | 6.63% | 6.5% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | 3.15B▲ 0% | 3.07B▼ 2.5% | 3.36B▲ 9.5% | 4.31B▲ 28.2% | 8.05B▲ 86.7% | 7.54B▼ 6.4% | 5.28B▼ 29.9% | 5.18B▼ 1.8% | 5.14B▼ 0.9% | 5.19B▲ 0% |
Operating Margin % | 17.18% | 18.01% | 18.77% | 19.35% | 27.33% | 28.29% | 22.1% | 21.71% | 20.91% | 20.95% |
Operating Income Growth % | 5.43% | -2.52% | 9.52% | 28.24% | 86.69% | -6.39% | -29.95% | -1.8% | -0.91% | - |
EBITDA | 4.39B | 4.25B | 4.55B | 6.09B | 10.22B | 9.67B | 7.45B | 7.54B | 7.58B | 7.24B |
EBITDA Margin % | 23.94% | 24.92% | 25.41% | 27.32% | 34.69% | 36.29% | 31.16% | 31.56% | 30.87% | 29.22% |
EBITDA Growth % | 6.62% | -3.19% | 7.16% | 33.72% | 67.87% | -5.38% | -22.99% | 1.22% | 0.64% | -3.68% |
D&A (Non-Cash Add-back) | 1.24B | 1.18B | 1.19B | 1.77B | 2.17B | 2.13B | 2.17B | 2.35B | 2.45B | 2.05B |
EBIT | 3.1B | 3.1B | 3.41B | 4.77B | 7.84B | 7.35B | 5.33B | 4.92B | 4.5B | 4.64B |
Net Interest Income | -155.2M | -127.7M | 30.4M | -202M | -230M | -166M | 14M | -161M | -235M | -205M |
Interest Income | 7.5M | 9.2M | 139M | 71M | 11M | 41M | 303M | 117M | 30M | 51M |
Interest Expense | 162.7M | 136.9M | 108.6M | 273M | 241M | 207M | 289M | 278M | 265M | 256M |
Other Income/Expense | -210.7M | -108.2M | -57.1M | 183M | -452M | -390M | -235M | -538M | -904M | -853M |
Pretax Income | 2.94B▲ 0% | 2.96B▲ 0.8% | 3.31B▲ 11.6% | 4.5B▲ 36.0% | 7.6B▲ 69.0% | 7.15B▼ 5.9% | 5.04B▼ 29.4% | 4.65B▼ 7.9% | 4.23B▼ 8.9% | 4.34B▲ 0% |
Pretax Margin % | 16.03% | 17.37% | 18.45% | 20.17% | 25.8% | 26.82% | 21.11% | 19.46% | 17.23% | 17.51% |
Income Tax | 469M | 555.6M | 873M | 849M | 1.25B | 818M | 823M | 747M | 619M | 650M |
Effective Tax Rate % | 15.96% | 18.76% | 26.41% | 18.89% | 16.46% | 11.45% | 16.32% | 16.08% | 14.62% | 14.98% |
Net Income | 2.49B▲ 0% | 2.65B▲ 6.4% | 2.56B▼ 3.5% | 3.65B▲ 42.6% | 6.43B▲ 76.4% | 7.21B▲ 12.1% | 4.76B▼ 33.9% | 3.9B▼ 18.2% | 3.61B▼ 7.3% | 3.69B▲ 0% |
Net Margin % | 13.6% | 15.55% | 14.28% | 16.36% | 21.84% | 27.06% | 19.94% | 16.33% | 14.71% | 14.89% |
Net Income Growth % | -2.41% | 6.37% | -3.53% | 42.58% | 76.44% | 12.06% | -33.92% | -18.16% | -7.31% | -2.02% |
Net Income (Continuing) | 2.47B | 2.41B | 2.43B | 3.65B | 6.35B | 6.33B | 4.22B | 3.9B | 3.61B | 3.69B |
Discontinued Operations | 22.3M | 244.6M | 124.9M | 0 | 86M | 881M | 543M | 0 | 14M | 0 |
Minority Interest | 9.6M | 12.3M | 11.3M | 11M | 10M | 8M | 4M | 7M | 7M | 8M |
EPS (Diluted) | 3.53▲ 0% | 3.73▲ 5.7% | 3.43▼ 8.0% | 4.89▲ 42.6% | 8.61▲ 76.1% | 9.64▲ 12.0% | 6.38▼ 33.8% | 5.29▼ 17.1% | 5.04▼ 4.7% | 5.19▲ 0% |
EPS Growth % | -3.29% | 5.67% | -8.04% | 42.57% | 76.07% | 11.96% | -33.82% | -17.08% | -4.73% | 0.39% |
EPS (Basic) | 3.58 | 3.78 | 3.48 | 4.97 | 8.77 | 9.80 | 6.44 | 5.33 | 5.07 | - |
Diluted Shares Outstanding | 706.1M | 710.2M | 725.5M | 718.7M | 736.8M | 737.1M | 743.1M | 737.2M | 711M | 711.2M |
Basic Shares Outstanding | 695.8M | 700.6M | 715M | 706.2M | 714.6M | 725.1M | 736.5M | 731M | 707.3M | 707.9M |
Dividend Payout Ratio | 15.18% | 16.35% | 20.61% | 16.87% | 11.53% | 11.35% | 17.23% | 19.7% | 24.29% | - |
DHR Balance Sheet
Danaher Corporation (DHR) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 6.85B | 7.09B | 25.6B | 13.8B | 11.65B | 15.88B | 13.94B | 9.5B | 12.76B | 13.94B |
Cash & Short-Term Investments | 630.3M | 787.8M | 19.91B | 6.04B | 2.59B | 6B | 5.86B | 2.08B | 4.62B | 5.7B |
Cash Only | 630.3M | 787.8M | 19.91B | 6.04B | 2.59B | 6B | 5.86B | 2.08B | 4.62B | 5.7B |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 3.52B | 3.11B | 3.27B | 4.81B | 5.44B | 5.06B | 4.64B | 4.39B | 3.91B | 3.82B |
Days Sales Outstanding | 70.13 | 66.62 | 66.6 | 78.79 | 67.45 | 69.38 | 70.85 | 67.11 | 58.13 | 58.93 |
Inventory | 1.84B | 1.63B | 1.63B | 2.29B | 2.77B | 2.77B | 2.59B | 2.33B | 2.49B | 2.61B |
Days Inventory Outstanding | 82.96 | 78.94 | 74.97 | 85.29 | 87.81 | 96.53 | 96.06 | 87.96 | 94.65 | 97.97 |
Other Current Assets | 857.1M | 1.56B | 787.6M | 665M | 82M | 1.36B | 71M | 79M | 1.74B | 1.81B |
Total Non-Current Assets | 39.8B | 40.74B | 36.48B | 62.36B | 71.54B | 68.47B | 70.55B | 68.05B | 70.71B | 69.61B |
Property, Plant & Equipment | 2.45B | 2.25B | 3.07B | 4.2B | 4.83B | 4.59B | 5.61B | 6.07B | 5.53B | 5.47B |
Fixed Asset Turnover | 7.47x | 7.58x | 5.84x | 5.30x | 6.10x | 5.80x | 4.26x | 3.93x | 4.44x | 4.35x |
Goodwill | 25.14B | 22.58B | 22.71B | 35.42B | 41.18B | 37.28B | 41.61B | 40.5B | 43.15B | 42.77B |
Intangible Assets | 11.67B | 10.28B | 9.75B | 21.28B | 22.84B | 19.82B | 20.75B | 18.57B | 17.82B | 17.17B |
Long-Term Investments | 45.4M | 38.3M | 33.7M | 27M | 1.32B | 2.16B | 1.7B | 1.81B | 0 | 3.01B |
Other Non-Current Assets | 492.9M | 5.59B | 923.4M | 1.43B | 1.36B | 4.61B | 896M | 1.09B | 4.21B | 4.21B |
Total Assets | 46.65B▲ 0% | 47.83B▲ 2.5% | 62.08B▲ 29.8% | 76.16B▲ 22.7% | 83.18B▲ 9.2% | 84.35B▲ 1.4% | 84.49B▲ 0.2% | 77.54B▼ 8.2% | 83.46B▲ 7.6% | 83.54B▲ 0% |
Asset Turnover | 0.39x | 0.36x | 0.29x | 0.29x | 0.35x | 0.32x | 0.28x | 0.31x | 0.29x | 0.30x |
Asset Growth % | 2.99% | 2.54% | 29.79% | 22.68% | 9.22% | 1.4% | 0.16% | -8.22% | 7.64% | 16.24% |
Total Current Liabilities | 4.79B | 4.84B | 4.93B | 7.4B | 8.14B | 8.39B | 8.27B | 6.8B | 6.81B | 7.46B |
Accounts Payable | 1.51B | 1.5B | 1.51B | 2.05B | 2.57B | 1.86B | 1.77B | 1.75B | 1.84B | 1.79B |
Days Payables Outstanding | 68.05 | 72.36 | 69.73 | 76.24 | 81.53 | 64.8 | 65.4 | 66.17 | 70.13 | 66.09 |
Short-Term Debt | 194.7M | 51.8M | 370.2M | 200M | 215M | 758M | 1.88B | 505M | 2M | 923M |
Deferred Revenue (Current) | 666M | 626.8M | 687.8M | 1.21B | 1.61B | 1.46B | 1.47B | 1.3B | 0 | 0 |
Other Current Liabilities | 978.5M | 1.41B | 921.1M | 1.93B | 1.59B | 2.48B | 1.4B | 1.34B | 4.96B | 4.75B |
Current Ratio | 1.43x | 1.47x | 5.19x | 1.86x | 1.43x | 1.89x | 1.68x | 1.40x | 1.87x | 1.87x |
Quick Ratio | 1.05x | 1.13x | 4.86x | 1.55x | 1.09x | 1.56x | 1.37x | 1.05x | 1.51x | 1.52x |
Cash Conversion Cycle | 85.04 | 73.2 | 71.85 | 87.83 | 73.74 | 101.11 | 101.51 | 88.9 | 82.66 | 90.81 |
Total Non-Current Liabilities | 15.49B | 14.76B | 26.87B | 28.98B | 29.87B | 25.87B | 22.72B | 21.19B | 24.12B | 23.14B |
Long-Term Debt | 10.33B | 9.69B | 21.52B | 21.19B | 22.17B | 19.09B | 16.71B | 15.5B | 18.42B | 17.56B |
Capital Lease Obligations | 0 | 0 | 652.2M | 785M | 889M | 772M | 954M | 968M | 0 | 0 |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 5.06B | 4.97B | 4.59B | 6.8B | 6.6B | 5.79B | 4.81B | 4.49B | 5.71B | 5.57B |
Total Liabilities | 20.28B | 19.61B | 31.8B | 36.38B | 38.01B | 34.26B | 31B | 27.99B | 30.93B | 30.59B |
Total Debt | 10.52B | 9.74B | 22.53B | 22.18B | 23.27B | 20.62B | 19.54B | 17.15B | 18.42B | 18.48B |
Net Debt | 9.89B | 8.95B | 2.61B | 16.14B | 20.69B | 14.62B | 13.67B | 15.07B | 13.8B | 12.78B |
Debt / Equity | 0.40x | 0.35x | 0.74x | 0.56x | 0.52x | 0.41x | 0.37x | 0.35x | 0.35x | 0.35x |
Debt / EBITDA | 2.40x | 2.29x | 4.95x | 3.64x | 2.28x | 2.13x | 2.62x | 2.28x | 2.43x | 2.55x |
Net Debt / EBITDA | 2.25x | 2.11x | 0.57x | 2.65x | 2.02x | 1.51x | 1.84x | 2.00x | 1.82x | 1.77x |
Interest Coverage | 19.06x | 22.64x | 31.44x | 17.47x | 32.53x | 35.52x | 18.45x | 17.71x | 16.97x | 18.13x |
Total Equity | 26.37B▲ 0% | 28.23B▲ 7.0% | 30.28B▲ 7.3% | 39.78B▲ 31.4% | 45.18B▲ 13.6% | 50.09B▲ 10.9% | 53.49B▲ 6.8% | 49.55B▼ 7.4% | 52.54B▲ 6.0% | 52.96B▲ 0% |
Equity Growth % | 14.26% | 7.05% | 7.28% | 31.36% | 13.58% | 10.88% | 6.79% | -7.37% | 6.04% | 14.62% |
Book Value per Share | 37.34 | 39.74 | 41.74 | 55.35 | 61.32 | 67.96 | 71.98 | 67.21 | 73.90 | 74.46 |
Total Shareholders' Equity | 26.36B | 28.21B | 30.27B | 39.77B | 45.17B | 50.08B | 53.49B | 49.54B | 52.53B | 52.95B |
Common Stock | 8.1M | 8.2M | 8.4M | 9M | 9M | 9M | 9M | 9M | 9M | 9M |
Retained Earnings | 22.81B | 25.16B | 24.17B | 27.16B | 32.83B | 39.2B | 41.07B | 44.19B | 46.89B | 47.64B |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.16B | -11.35B | 0 |
Accumulated OCI | -1.99B | -2.79B | -3.07B | -368M | -1.03B | -2.87B | -1.75B | -3.22B | -207M | -593M |
Minority Interest | 9.6M | 12.3M | 11.3M | 11M | 10M | 8M | 4M | 7M | 7M | 8M |
DHR Cash Flow Statement
Danaher Corporation (DHR) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 3.48B | 4.02B | 3.95B | 6.21B | 8.36B | 8.52B | 7.16B | 6.69B | 6.42B | 6.44B |
Operating CF Margin % | 18.97% | 23.59% | 22.06% | 27.86% | 28.38% | 31.97% | 29.99% | 28.01% | 26.12% | - |
Operating CF Growth % | -1.25% | 15.65% | -1.75% | 57.1% | 34.63% | 1.93% | -15.91% | -6.64% | -4.07% | 10.9% |
Net Income | 2.47B | 2.65B | 2.43B | 3.65B | 6.35B | 7.21B | 4.22B | 3.9B | 3.61B | 3.69B |
Depreciation & Amortization | 1.24B | 1.31B | 1.19B | 1.77B | 2.17B | 2.22B | 2.17B | 2.35B | 2.45B | 2.38B |
Stock-Based Compensation | 139.4M | 151.4M | 158.8M | 187M | 184M | 295M | 306M | 288M | 298M | 378M |
Deferred Taxes | -426.9M | -195.1M | -415.2M | -462M | -318M | -559M | 0 | 0 | -440M | -440M |
Other Non-Cash Items | 410.2M | 197.2M | 709.4M | 457M | 601M | 830M | 864M | -117M | 1.21B | 884M |
Working Capital Changes | -353M | -90.1M | -123.2M | 605M | -658M | -1.52B | -393M | 266M | -710M | -454M |
Change in Receivables | -161.4M | -58.3M | -156.4M | -264M | -611M | -477M | 322M | 331M | -216M | -239M |
Change in Inventory | -27.4M | -143.3M | -21.9M | -123M | -502M | -486M | 185M | 147M | -58M | -24M |
Change in Payables | -54.4M | 225.8M | 18.1M | 227M | 549M | 5M | -149M | 19M | 9M | 29M |
Cash from Investing | -843.4M | -2.95B | -1.24B | -21.24B | -12.99B | -2.23B | -7.08B | -1.98B | -1.2B | -1.2B |
Capital Expenditures | -570.7M | -584M | -635.5M | -791M | -1.29B | -1.15B | -1.38B | -1.39B | -1.16B | -1.15B |
CapEx % of Revenue | 3.11% | 3.43% | 3.55% | 3.55% | 4.39% | 4.32% | 5.79% | 5.83% | 4.71% | 4.63% |
Acquisitions | -385.8M | -2.17B | -331.3M | -20.14B | -10.94B | -637M | -5.61B | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -272.7M | -65M | 28.9M | 26M | 50M | 60M | 23M | -511M | -153M | -161M |
Cash from Financing | -3.1B | -797M | 16.37B | 1.01B | 1.29B | -2.57B | -273M | -8.38B | -2.96B | -1.66B |
Debt Issued (Net) | -2.66B | -442M | 13.35B | -1.9B | 1.97B | -1.69B | -1.63B | -1.67B | 1.04B | 308M |
Equity Issued (Net) | 68.8M | 96M | 3.82B | 3.55B | 86M | 31M | 68M | -5.82B | -3B | -2.02B |
Dividends Paid | -378.3M | -433.4M | -526.7M | -615M | -742M | -818M | -821M | -768M | -878M | -910M |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.98B | -3.09B | -2.02B |
Other Financing | -124.2M | -17.6M | -274.7M | -29M | -16M | -95M | 2.11B | -131M | -125M | 961M |
Net Change in Cash | -333.4M▲ 0% | 157.7M▲ 147.3% | 19.12B▲ 12027.1% | -13.88B▼ 172.6% | -3.45B▲ 75.1% | 3.41B▲ 198.8% | -131M▼ 103.8% | -3.79B▼ 2790.1% | 2.54B▲ 167.0% | 4.37B▲ 0% |
Free Cash Flow | 2.91B▲ 0% | 3.44B▲ 18.3% | 3.32B▼ 3.5% | 5.42B▲ 63.4% | 7.06B▲ 30.4% | 7.37B▲ 4.3% | 5.78B▼ 21.5% | 5.3B▼ 8.4% | 5.26B▼ 0.7% | 5.29B▲ 0% |
FCF Margin % | 15.86% | 20.17% | 18.51% | 24.31% | 23.98% | 27.65% | 24.2% | 22.18% | 21.41% | 21.35% |
FCF Growth % | -0.86% | 18.26% | -3.55% | 63.35% | 30.4% | 4.29% | -21.53% | -8.39% | -0.68% | 7.94% |
FCF per Share | 4.12 | 4.84 | 4.57 | 7.54 | 9.59 | 9.99 | 7.78 | 7.18 | 7.40 | 7.44 |
FCF Conversion (FCF/Net Income) | 1.40x | 1.52x | 1.55x | 1.70x | 1.30x | 1.18x | 1.50x | 1.72x | 1.78x | 1.43x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -35M |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10M |
DHR Key Ratios
Danaher Corporation (DHR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 10.08% | 9.71% | 8.74% | 10.41% | 15.14% | 15.13% | 9.2% | 7.57% | 7.08% | 7.06% |
Return on Invested Capital (ROIC) | 6.69% | 6.27% | 7.2% | 7.28% | 9.92% | 8.66% | 6% | 5.9% | 5.88% | 5.85% |
Gross Margin | 55.81% | 55.75% | 55.74% | 55.98% | 60.95% | 60.76% | 58.74% | 59.5% | 60.93% | 60.68% |
Net Margin | 13.6% | 15.55% | 14.28% | 16.36% | 21.84% | 27.06% | 19.94% | 16.33% | 14.71% | 14.89% |
Debt / Equity | 0.40x | 0.35x | 0.74x | 0.56x | 0.52x | 0.41x | 0.37x | 0.35x | 0.35x | 0.35x |
Interest Coverage | 19.06x | 22.64x | 31.44x | 17.47x | 32.53x | 35.52x | 18.45x | 17.71x | 16.97x | 18.13x |
FCF Conversion | 1.40x | 1.52x | 1.55x | 1.70x | 1.30x | 1.18x | 1.50x | 1.72x | 1.78x | 1.43x |
Revenue Growth | 8.57% | -6.99% | 5.06% | 24.41% | 32.17% | -9.54% | -10.33% | -0.06% | 2.9% | 4.02% |
Related:DHR Dividend History·DHR Revenue History·DHR Price History·DHR P/E History·DHR Financial Ratios·DHR Institutional Holders
DHR SEC Filings & Documents
Danaher Corporation (DHR) SEC filings — annual & quarterly reports (10-K, 10-Q)
DHR Frequently Asked Questions
Danaher Corporation (DHR) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Danaher Corporation (DHR) reported $24.78B in revenue for fiscal year 2025. This represents a 1268% increase from $1.81B in 1996.
Danaher Corporation (DHR) grew revenue by 2.9% over the past year. Growth has been modest.
Yes, Danaher Corporation (DHR) is profitable, generating $3.69B in net income for fiscal year 2025 (14.7% net margin).
Dividend & Returns
Yes, Danaher Corporation (DHR) pays a dividend with a yield of 0.70%. This makes it attractive for income-focused investors.
Danaher Corporation (DHR) has a return on equity (ROE) of 7.1%. This is below average, suggesting room for improvement.
Danaher Corporation (DHR) generated $5.29B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.